Scholtz & Company’s Beam Therapeutics BEAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,875	Closed	-$250K	–	62
2021 Q3	$250K	Sell	2,875 -70	-2%	-$6.09K	0.09%	61
2021 Q2	$379K	Buy	+2,945	New	+$379K	0.13%	62